News
NRG Gets A Boost of £2.68 Mn For Neurodegenerative Diseases
NRG Therapeutics, a neuroscience firm, has been presented with the Biomedical Catalyst award. The £2.68 million package will be used to advance the pre-clinical development of the company's innovative small molecule disease-modifying medicines for the treatment of Parkinson's disease,...
News
MoU Inked By The UK And Sweden To Engage In Lifesciences
The United Kingdom and Sweden have reached a deal through an MoU recognising their existing bilateral collaboration in the biological sciences. The goal of the MoU is to foster collaboration among participants in the health, research, as well as innovation systems...
News
Scientists Find A Possible Antiviral Treatment For Monkeypox
Scientists have discovered a viable antiviral therapy for monkeypox, albeit the illness remains a considerably less serious threat than COVID, according to the researchers. As per new research on historical outbreaks of monkeypox in the UK, a patient seemed...
News
New Standards To Speed Up Development of Paediatric Drugs
A new approach for extrapolating clinical trial data using adult research aims to speed up and lower the cost of testing and approval of medicines for children. The methodology for attaining such advantages is outlined in a proposed guideline...
News
Researchers Uncover Anti-Cancer Compounds In The Corals
The ocean below is filled with riddles, but scientists have recently discovered one of its best-kept mysteries. For the past 25 years, researchers have been looking for the origin of a natural chemical that has shown promise in preliminary...
Industry Reports
Dr. Reddys Says Russia Sales Booming As Big Pharma Retreats
While many western biopharma businesses have shied away from Russia since its invasion of Ukraine, some of those in India have stepped in to fill the hole by providing the Kremlin with medical supplies. Dr. Reddy's Laboratories has been...
News
New Molecular Target For Cancer Therapy Found Through Study
The Ohio State University Comprehensive Cancer Center, Richard J. Solove Research Institute, and James Cancer Hospital have discovered a new molecular therapeutic target that could lead to the development of new cancer treatments with fewer side effects.
Previous research has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read